Intas Selgin Pet 10mg Tablets (Selegiline hydrochloride) for Dogs
This is a 10 mg selegiline HCl tablet pack designed for oral administration in dogs, manufactured by Intas Animal Health. It acts as a selective MAO-B inhibitor to address emotional and neurological issues, with high oral bioavailability (65-95%) in canines.
-
Composition : Selegiline hydrochloride: 10 mg per tablet (equivalent to approximately 8.37 mg base selegiline).
- Excipients for tablet formulation (non-active binders and coatings).
Indications :
- Treatment of behavioral disorders of emotional origin, such as depression and anxiety.
- Unsuccessful management with behavioral therapy alone.
- Support for age-related cognitive dysfunction in dogs.
Features :
- Increases monoamine neurotransmitter levels to improve mood and reduce anxiety.
- Well-tolerated with minimal side effects at recommended doses.
- Effective after 2+ months of consistent use, stabilizing clinical signs.
Directions for Use:
-
Dosage: 0.5 mg selegiline HCl per kg body weight once daily (e.g., 1 tablet for 17-21 kg dog).
-
Give orally in the morning after light breakfast; adjust based on weight bands.
-
Minimum 2 months treatment; continue until condition stabilizes, then taper off under vet guidance.
A licensed vendor partner will deliver this medicine to you. Once the pharmacy accepts your order, the pharmacy details will be shared with you. Acceptance of your order is based on the validity of your doctor's prescription and the availability of the medicine.
Disclaimer:
Supertails' sole intention is to ensure that its consumers get information that is expert-reviewed, accurate, and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

Description
This is a 10 mg selegiline HCl tablet pack designed for oral administration in dogs, manufactured by Intas Animal Health. It acts as a selective MAO-B inhibitor to address emotional and neurological issues, with high oral bioavailability (65-95%) in canines.
-
Composition : Selegiline hydrochloride: 10 mg per tablet (equivalent to approximately 8.37 mg base selegiline).
- Excipients for tablet formulation (non-active binders and coatings).
Indications :
- Treatment of behavioral disorders of emotional origin, such as depression and anxiety.
- Unsuccessful management with behavioral therapy alone.
- Support for age-related cognitive dysfunction in dogs.
Features :
- Increases monoamine neurotransmitter levels to improve mood and reduce anxiety.
- Well-tolerated with minimal side effects at recommended doses.
- Effective after 2+ months of consistent use, stabilizing clinical signs.
Directions for Use:
-
Dosage: 0.5 mg selegiline HCl per kg body weight once daily (e.g., 1 tablet for 17-21 kg dog).
-
Give orally in the morning after light breakfast; adjust based on weight bands.
-
Minimum 2 months treatment; continue until condition stabilizes, then taper off under vet guidance.
A licensed vendor partner will deliver this medicine to you. Once the pharmacy accepts your order, the pharmacy details will be shared with you. Acceptance of your order is based on the validity of your doctor's prescription and the availability of the medicine.
Disclaimer:
Supertails' sole intention is to ensure that its consumers get information that is expert-reviewed, accurate, and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.





















